ALX Oncology Holdings Inc (ALXO)
15.36
-1.26
(-7.58%)
USD |
NASDAQ |
May 03, 16:00
15.36
0.00 (0.00%)
After-Hours: 20:00
ALX Oncology Holdings Price to Book Value: 4.061 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 4.061 |
| May 02, 2024 | 4.394 |
| May 01, 2024 | 4.478 |
| April 30, 2024 | 4.499 |
| April 29, 2024 | 4.476 |
| April 26, 2024 | 4.457 |
| April 25, 2024 | 4.460 |
| April 24, 2024 | 4.288 |
| April 23, 2024 | 4.098 |
| April 22, 2024 | 3.762 |
| April 19, 2024 | 4.124 |
| April 18, 2024 | 4.161 |
| April 17, 2024 | 4.251 |
| April 16, 2024 | 3.831 |
| April 15, 2024 | 3.408 |
| April 12, 2024 | 3.445 |
| April 11, 2024 | 3.537 |
| April 10, 2024 | 3.186 |
| April 09, 2024 | 3.262 |
| April 08, 2024 | 3.209 |
| April 05, 2024 | 3.233 |
| April 04, 2024 | 2.971 |
| April 03, 2024 | 2.855 |
| April 02, 2024 | 2.834 |
| April 01, 2024 | 2.913 |
| Date | Value |
|---|---|
| March 28, 2024 | 2.948 |
| March 27, 2024 | 3.016 |
| March 26, 2024 | 2.958 |
| March 25, 2024 | 3.098 |
| March 22, 2024 | 3.104 |
| March 21, 2024 | 3.307 |
| March 20, 2024 | 3.172 |
| March 19, 2024 | 3.056 |
| March 18, 2024 | 2.895 |
| March 15, 2024 | 2.987 |
| March 14, 2024 | 2.948 |
| March 13, 2024 | 3.067 |
| March 12, 2024 | 3.270 |
| March 11, 2024 | 3.558 |
| March 08, 2024 | 4.021 |
| March 07, 2024 | 4.293 |
| March 06, 2024 | 3.905 |
| March 05, 2024 | 3.905 |
| March 04, 2024 | 3.886 |
| March 01, 2024 | 3.973 |
| February 29, 2024 | 3.878 |
| February 28, 2024 | 3.820 |
| February 27, 2024 | 4.321 |
| February 26, 2024 | 4.331 |
| February 23, 2024 | 4.173 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6974
Minimum
Jun 16 2022
16.53
Maximum
Dec 10 2020
3.528
Average
2.284
Median
Price to Book Value Benchmarks
| Bristol-Myers Squibb Co | 5.408 |
| Nurix Therapeutics Inc | 4.625 |
| Exelixis Inc | 2.998 |
| Geron Corp | 6.759 |
| Verastem Inc | 4.808 |
Price to Book Value Related Metrics
| PS Ratio | 180.85 |
| Price | 15.36 |
| Earnings Yield | -24.35% |
| Market Cap | 770.34M |